Alphagan® P 0.1% : Patient - Talking to Your Doctor

Does your doctor know about your overall health?
Many glaucoma patients are diagnosed with and/or treated for additional medical conditions. The medications for these conditions may counteract some glaucoma medications.

Many glaucoma patients may have coexisting systemic disorders¹
Glaucoma treatment is complicated by the following medical conditions¹:

It is very important to tell your doctor about your other medical conditions and what prescriptions you take. In doing so, your doctor will choose the right glaucoma medication that is best for you.

Let your doctor know if you've been diagnosed with or treated for the following:

Cardiovascular or heart disorders

Metabolic disorders, such as diabetes

Lung disorders, such as asthma or COPD

Other disorders, including sexual dysfunction or anxiety/depression

If you are being treated with medication(s) for the above conditions, the medication(s) may interfere with your glaucoma medication.

Indication: ALPHAGAN^® P 0.1% ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Important Safety Information
Contraindication: ALPHAGAN^® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.
Precautions: Although ALPHAGAN^® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN^® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse events occurring in approximately 5% to 9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.

Please click here for full product information.

1. Gottfredsdottir MS, Allingham RR, Shields MB. Physicians' guide to interactions between glaucoma and systemic medications.
J Glaucoma. 1997;6(6):377-383.